×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ETNB – 89bio, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ETNB
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/15
08:10 am
etnb
89bio Presents New Analyses Evaluating Pegozafermin and Potential Benefit of Non-Invasive Tests from the ENLIVEN Phase 2b Trial in MASH Patients at AASLD The Liver Meeting® 2024 [Yahoo! Finance]
Medium
Report
89bio Presents New Analyses Evaluating Pegozafermin and Potential Benefit of Non-Invasive Tests from the ENLIVEN Phase 2b Trial in MASH Patients at AASLD The Liver Meeting® 2024 [Yahoo! Finance]
11/15
08:05 am
etnb
89bio Presents New Analyses Evaluating Pegozafermin and Potential Benefit of Non-Invasive Tests from the ENLIVEN Phase 2b Trial in MASH Patients at AASLD The Liver Meeting® 2024
Medium
Report
89bio Presents New Analyses Evaluating Pegozafermin and Potential Benefit of Non-Invasive Tests from the ENLIVEN Phase 2b Trial in MASH Patients at AASLD The Liver Meeting® 2024
11/12
11:58 pm
etnb
89bio, Inc. Announces Upsized Pricing of $125.0 Million Public Offering of Common Stock and Pre-Funded Warrants
Low
Report
89bio, Inc. Announces Upsized Pricing of $125.0 Million Public Offering of Common Stock and Pre-Funded Warrants
11/12
04:12 pm
etnb
89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants [Yahoo! Finance]
Low
Report
89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants [Yahoo! Finance]
11/12
04:01 pm
etnb
89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
Low
Report
89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
11/11
08:09 am
etnb
89bio, Inc. (NASDAQ: ETNB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $29.00 price target on the stock.
Medium
Report
89bio, Inc. (NASDAQ: ETNB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $29.00 price target on the stock.
11/8
01:45 pm
etnb
89bio, Inc. (NASDAQ: ETNB) had its price target lowered by analysts at Raymond James from $53.00 to $49.00. They now have a "strong-buy" rating on the stock.
Low
Report
89bio, Inc. (NASDAQ: ETNB) had its price target lowered by analysts at Raymond James from $53.00 to $49.00. They now have a "strong-buy" rating on the stock.
11/7
04:05 pm
etnb
89bio Reports Third Quarter 2024 Financial Results and Corporate Updates
Medium
Report
89bio Reports Third Quarter 2024 Financial Results and Corporate Updates
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/18
08:19 pm
etnb
Form SC 13D/A 89bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Low
Report
Form SC 13D/A 89bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
11/18
08:14 pm
etnb
Form 4 89bio, Inc. For: Nov 14 Filed by: RA Capital Healthcare Fund LP
Low
Report
Form 4 89bio, Inc. For: Nov 14 Filed by: RA Capital Healthcare Fund LP
11/14
04:31 pm
etnb
Form SC 13G/A 89bio, Inc. Filed by: BIOTECHNOLOGY VALUE FUND L P
Medium
Report
Form SC 13G/A 89bio, Inc. Filed by: BIOTECHNOLOGY VALUE FUND L P
11/14
12:48 pm
etnb
Form SC 13G/A 89bio, Inc. Filed by: JANUS HENDERSON GROUP PLC
Low
Report
Form SC 13G/A 89bio, Inc. Filed by: JANUS HENDERSON GROUP PLC
11/14
06:47 am
etnb
Form SC 13G/A 89bio, Inc. Filed by: RTW INVESTMENTS, LP
Low
Report
Form SC 13G/A 89bio, Inc. Filed by: RTW INVESTMENTS, LP
11/14
06:06 am
etnb
Form 8-K 89bio, Inc. For: Nov 12
Medium
Report
Form 8-K 89bio, Inc. For: Nov 12
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
11/15
Form 8-K 89bio, Inc. For: Nov 13
16.7%
3/18 Q4/2019 12/31/2019 EPS 2.580 ZacksConsensus -0.810 ActVsEst 3.390 - Beat 13.1%
11/13 Form 4 89bio, Inc. For: Nov 11 Filed by: Kolchinsky Peter 12.9%
4/23 Form 8-K 89bio, Inc. For: Apr 17 10.9%
11/25 Form SC 13G 89bio, Inc. Filed by: Venrock Healthcare Capital Partners II, L.P. 9.0%
2/21 89bio to Present at the SVB Leerink 9th Annual Global Healthcare Conference 7.7%
3/26 Form 8-K 89bio, Inc. For: Mar 23 7.6%
2/14 Form SC 13G 89bio, Inc. Filed by: Nussbaum Ran 5.5%
11/8 Form S-1MEF 89bio, Inc. 4.0%
11/12 Form 424B4 89bio, Inc. 3.8%
3/18 Q4/2019 12/31/2019 EPS 2.580 ZacksConsensus -0.810 ActVsEst 3.390 - Beat 13.1%
11/13 Form 4 89bio, Inc. For: Nov 11 Filed by: Kolchinsky Peter 12.9%
4/23 Form 8-K 89bio, Inc. For: Apr 17 10.9%
11/25 Form SC 13G 89bio, Inc. Filed by: Venrock Healthcare Capital Partners II, L.P. 9.0%
2/21 89bio to Present at the SVB Leerink 9th Annual Global Healthcare Conference 7.7%
3/26 Form 8-K 89bio, Inc. For: Mar 23 7.6%
2/14 Form SC 13G 89bio, Inc. Filed by: Nussbaum Ran 5.5%
11/8 Form S-1MEF 89bio, Inc. 4.0%
11/12 Form 424B4 89bio, Inc. 3.8%
TOP News Decliners
12/18
Form 10-Q 89bio, Inc. For: Sep 30
-14.9%
4/29 89bio (NASDAQ: ETNB) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $28.00 price target on the stock. -9.5%
12/9 89bio (NASDAQ: ETNB) is now covered by analysts at Bank of America Corp. They set a "neutral" rating on the stock. -7.7%
11/12 89Bio debuts IPO [Reuters] -5.0%
12/31 Form 8-K 89bio, Inc. For: Dec 24 -4.5%
4/7 89bio (NASDAQ: ETNB) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $24.00 price target on the stock. -4.2%
4/23 89bio (NASDAQ: ETNB) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -3.8%
2/19 Form 4 89bio, Inc. For: Feb 14 Filed by: PALEKAR ROHAN -3.7%
11/21 Form SC 13D 89bio, Inc. Filed by: Longitude Capital Partners III, LLC -2.3%
4/7 89bio (NASDAQ: ETNB) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -2.1%
4/29 89bio (NASDAQ: ETNB) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $28.00 price target on the stock. -9.5%
12/9 89bio (NASDAQ: ETNB) is now covered by analysts at Bank of America Corp. They set a "neutral" rating on the stock. -7.7%
11/12 89Bio debuts IPO [Reuters] -5.0%
12/31 Form 8-K 89bio, Inc. For: Dec 24 -4.5%
4/7 89bio (NASDAQ: ETNB) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $24.00 price target on the stock. -4.2%
4/23 89bio (NASDAQ: ETNB) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -3.8%
2/19 Form 4 89bio, Inc. For: Feb 14 Filed by: PALEKAR ROHAN -3.7%
11/21 Form SC 13D 89bio, Inc. Filed by: Longitude Capital Partners III, LLC -2.3%
4/7 89bio (NASDAQ: ETNB) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -2.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: